These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
517 related items for PubMed ID: 11160247
1. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation. Wang R, Zhang L, Zhang X, Moreno J, Luo X, Tondravi M, Shi Y. J Immunol; 2001 Feb 01; 166(3):1983-90. PubMed ID: 11160247 [Abstract] [Full Text] [Related]
2. Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells. Wang R, Zhang L, Zhang X, Moreno J, Celluzzi C, Tondravi M, Shi Y. Eur J Immunol; 2002 Apr 01; 32(4):1090-8. PubMed ID: 11920576 [Abstract] [Full Text] [Related]
3. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. J Immunol; 2001 Aug 01; 167(3):1347-52. PubMed ID: 11466352 [Abstract] [Full Text] [Related]
5. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway. Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW. Exp Cell Res; 1999 Oct 10; 252(1):96-103. PubMed ID: 10502402 [Abstract] [Full Text] [Related]
6. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Jeremias I, Herr I, Boehler T, Debatin KM. Eur J Immunol; 1998 Jan 10; 28(1):143-52. PubMed ID: 9485194 [Abstract] [Full Text] [Related]
7. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. Kaplan MJ, Ray D, Mo RR, Yung RL, Richardson BC. J Immunol; 2000 Mar 15; 164(6):2897-904. PubMed ID: 10706675 [Abstract] [Full Text] [Related]
8. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Mariani SM, Krammer PH. Eur J Immunol; 1998 May 15; 28(5):1492-8. PubMed ID: 9603453 [Abstract] [Full Text] [Related]
9. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I. J Clin Pathol; 2006 Jan 15; 59(1):56-63. PubMed ID: 16394281 [Abstract] [Full Text] [Related]
11. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
12. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. Ursini-Siegel J, Zhang W, Altmeyer A, Hatada EN, Do RK, Yagita H, Chen-Kiang S. J Immunol; 2002 Nov 15; 169(10):5505-13. PubMed ID: 12421926 [Abstract] [Full Text] [Related]
13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
14. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA. J Immunol; 2001 Apr 15; 166(8):4949-57. PubMed ID: 11290773 [Abstract] [Full Text] [Related]
15. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N, Poulaki V, Mitsiades C, Tsokos M. Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151 [Abstract] [Full Text] [Related]
16. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells. Liu S, Yu Y, Zhang M, Wang W, Cao X. J Immunol; 2001 May 01; 166(9):5407-15. PubMed ID: 11313377 [Abstract] [Full Text] [Related]
19. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. Yu Q, Gu JX, Kovacs C, Freedman J, Thomas EK, Ostrowski MA. J Immunol; 2003 Feb 15; 170(4):1797-805. PubMed ID: 12574344 [Abstract] [Full Text] [Related]
20. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M, Weller M. Cell Death Differ; 2003 Sep 15; 10(9):1078-89. PubMed ID: 12934082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]